Regulatory Science of Medical Products
Online ISSN : 2189-0447
Print ISSN : 2185-7113
ISSN-L : 2185-7113
A Current Global Strategy in a Medtech Startup
Takahiro UCHIDAHiroaki KOBAYASHITaiki ISHIKURAIn GUTOTetsuo MURAKAMIShohei NAKANO
Author information
JOURNAL FREE ACCESS

2015 Volume 5 Issue 3 Pages 211-217

Details
Abstract
Medical device industry in the world is growing. The current meditech industry in Japan is not very active, resulting in over 7bilion US dollar annual deficit in trade. However, given lots of technologies, high capability of manufacturing, and high-level healthcare, Japan has potentials to lead the meditech industry in the world. In order to be more competitive in the arena, global strategies should be necessary. There are several points to consider for a global strategy in medical device development. Those include the Obama Care, Cost-effectiveness, Reverse innovation, Global clinical trial, and Digital-health. Given these keywords, strategies in medical device innovation among startups should become more global rather than just for a country.
Content from these authors
© 2015 Society for Regulatory Science of Medical Products
Previous article Next article
feedback
Top